Mechanismen der Fibrose und ihre Translation in die Klinik
Authors:
- 14 June 2014
- journal article
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 73 (5) , 458-460
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of sclerodermaNature, 2013
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary HypertensionNew England Journal of Medicine, 2013
- Riociguat for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2013
- Morphogen Pathways in Systemic SclerosisCurrent Rheumatology Reports, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosisAnnals of the Rheumatic Diseases, 2012
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisNature Communications, 2012
- Platelet-derived serotonin links vascular disease and tissue fibrosisJournal of Experimental Medicine, 2011
- SclerodermaNew England Journal of Medicine, 2009
- Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192Arthritis & Rheumatism, 2007